Evidence map›Paper›PMID 28690751›Full record

ArticleThe Pan African medical journal2017

[Ocular Behçet].

Ahmed Alami, Mohamed Kriet, Karim Reda, Abdelkader Laktaoui, Abdelbaare Oubaaz

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Orbital Vasculitides-Differential Diagnosis.Current rheumatology reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ahmed AlamiService d'Ophtalmologie, 3 Hôpital Militaire de Laâyoune, Maroc.
Mohamed KrietService d'Ophtalmologie, Hôpital Militaire Avicenne de Marrakech, Maroc.
Karim RedaService d'Ophtalmologie, Hôpital Militaire d'Instruction Mohamed V de Rabat, Maroc.
Abdelkader LaktaouiService d'Ophtalmologie, Hôpital Militaire Moulay Ismail de Meknes, Maroc.
Abdelbaare OubaazService d'Ophtalmologie, Hôpital Militaire d'Instruction Mohamed V de Rabat, Maroc.
Hôpital Militaire Avicenne · MAHôpital Militaire Moulay Ismail · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our study aimed to determine the clinical, therapeutic and prognostic features of ocular involvement in patients with Behçet's disease treated in our Department of ophthalmology. We conducted a retrospective data collection from medical records of 20 patients treated at the military hospital in Laayoune. All patients underwent complete ophthalmological examination and fluorescein angiography if necessary. OCT exam was performed in two patients. Ten patients had anterior uveitis, complicated in one case by ocular hypertonia; two patients had intermediate uveitis; eight patients had posterior segment involvement complicated in one case by intravitreal hemorrhage. Behcet's Disease (BD) is an systemic idiopathic inflammatory disease currently classified within primary non-necrotizing vasculitis. Ocular involvement is common and severe in Behçet's disease, with the potential to compromise the visual prognosis. Behcet's disease is common in Morocco. It can compromise patient's visual prognosis making the collaboration between ophthalmologists and internists particularly important.

Indexed as

AdultBehcet SyndromeEye DiseasesFemaleFluorescein AngiographyHospitals, MilitaryHumansMaleMoroccoPrognosisRetrospective StudiesSeverity of Illness IndexUveitis, AnteriorBehcet's disease (BD)immunosuppressiveuveitisvasculitisvisual function

Identifiers

PMID28690751
PMCPMC5491746
OpenAlexW4233606029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.